AI in IBD: Redefining Clinical Trials and the Future of Gastroenterology

from EMJ Podcast: Insights For Healthcare Professionals · host EMJ

Byrne discusses Dova's recent Late Breaker at the United European Gastroenterology (UEG) Week 2025, where AI re-analysis uncovered treatment effects missed by human readers. He explains how AI may soon become integral to clinical trial design, regulatory review, and drug approval, while predicting how AI-human partnerships will define the future of gastroenterology. Timestamps:01:05 – AI in the TITRATE trial03:18 – Validating clinical endpoints04:16 – AI and human readers16:53 – The next frontier in gastrointestinal AI

Episode metadata supplied by the publisher feed · Published Jan 8, 2026

Embed this episode

Attribution link and audio player

Ready to play

AI in IBD: Redefining Clinical Trials and the Future of Gastroenterology

0:00 10:16

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of EMJ Podcast: Insights For Healthcare Professionals?

This episode is 10 minutes long.

When was this EMJ Podcast: Insights For Healthcare Professionals episode published?

This episode was published on January 8, 2026.

Can I download this EMJ Podcast: Insights For Healthcare Professionals episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!